Immunoglobulin Replacement Therapy in Primary Antibody Deficiency Diseases – Maximizing Success

Publisher： Karger

E-ISSN： 1423-0097|136|3|217-229

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.136, Iss.3, 2005-03, pp. : 217-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Streptococcus pneumoniae antibody titres in patients with primary antibody deficiency receiving intravenous immunoglobulin (IVIG) compared to subcutaneous immunoglobulin (SCIG)

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 182, Iss. 1, 2015-10 ,pp. : 51-56

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and tolerability of 16% subcutaneous immunoglobulin compared with 20% subcutaneous immunoglobulin in primary antibody deficiency

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 3, 2015-09 ,pp. : 441-450

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hemolysis in patients with antibody deficiencies on immunoglobulin replacement treatment

By  

TRANSFUSION, Vol. 55, Iss. 5, 2015-05 ,pp. : 1067-1074

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of Intravenous Gammaglobulin for Immunoglobulin G Subclass and/or Antibody Deficiency in Adults

By  

International Archives of Allergy and Immunology, Vol. 149, Iss. 3, 2009-02 ,pp. : 267-274

Karger

Access to resources Recommend Favorite

Co-Occurrence of Chronic Spontaneous Urticaria with Immunoglobulin A Deficiency and Autoimmune Diseases

By  

International Archives of Allergy and Immunology, Vol. 169, Iss. 2, 2016-04 ,pp. : 130-134

Karger

Access to resources Recommend Favorite